Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548652 · ClinicalTrials.gov registry record · NA
Role of Apathy in the Effectiveness of Weight Loss Interventions
A NA study, sponsored by VA Nebraska Western Iowa Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT00548652: Completed NA study, sponsored by VA Nebraska Western Iowa Health Care System.
NCT00548652 is a NA study that has completed, run by VA Nebraska Western Iowa Health Care System. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00548652, a NA study, has completed, sponsored by VA Nebraska Western Iowa Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether treating apathy with methylphenidate or medical Crisis counselling will increase adherence to weight loss programs thereby increasing their effectiveness
Primary Outcome
Apathy Evaluation Scale (AES) measures apathy over the previous four weeks Scale range: 18 (minimum score)- 72 (Maximum score) Higher scores indicate higher apathy Better outcome would be reduction in the score
Interventions
- BEHAVIORAL MOVE
- BEHAVIORAL medical crisis councelling
- DRUG methyphenidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-05 |
| Phase | NA |
What the finished NCT00548652 record still lists
NCT00548652 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which MOVE is the first listed.
NCT00548652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00548652 about?
NCT00548652 is a clinical study titled "Role of Apathy in the Effectiveness of Weight Loss Interventions". The purpose of this study is to determine whether treating apathy with methylphenidate or medical Crisis counselling will increase adherence to weight loss programs thereby increasing their effectiveness
What is the current status of trial NCT00548652?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2007-08. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00548652?
The interventions under investigation include: MOVE (BEHAVIORAL), medical crisis councelling (BEHAVIORAL), methyphenidate (DRUG).
Who is sponsoring clinical trial NCT00548652?
This trial is sponsored by VA Nebraska Western Iowa Health Care System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00548652's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia